141 related articles for article (PubMed ID: 17637563)
1. The interdependence between catalytic activity, conformational stability, and cytotoxicity of onconase.
Schulenburg C; Ardelt B; Ardelt W; Arnold U; Shogen K; Ulbrich-Hofmann R; Darzynkiewicz Z
Cancer Biol Ther; 2007 Aug; 6(8):1233-9. PubMed ID: 17637563
[TBL] [Abstract][Full Text] [Related]
2. Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes.
Ardelt W; Shogen K; Darzynkiewicz Z
Curr Pharm Biotechnol; 2008 Jun; 9(3):215-25. PubMed ID: 18673287
[TBL] [Abstract][Full Text] [Related]
3. Cytostatic and cytotoxic properties of Amphinase: a novel cytotoxic ribonuclease from Rana pipiens oocytes.
Ardelt B; Ardelt W; Pozarowski P; Kunicki J; Shogen K; Darzynkiewicz Z
Cell Cycle; 2007 Dec; 6(24):3097-102. PubMed ID: 18073526
[TBL] [Abstract][Full Text] [Related]
4. Onconase cytotoxicity relies on the distribution of its positive charge.
Turcotte RF; Lavis LD; Raines RT
FEBS J; 2009 Jul; 276(14):3846-57. PubMed ID: 19523116
[TBL] [Abstract][Full Text] [Related]
5. Onconase dimerization through 3D domain swapping: structural investigations and increase in the apoptotic effect in cancer cells.
Fagagnini A; Pica A; Fasoli S; Montioli R; Donadelli M; Cordani M; Butturini E; Acquasaliente L; Picone D; Gotte G
Biochem J; 2017 Nov; 474(22):3767-3781. PubMed ID: 28963346
[TBL] [Abstract][Full Text] [Related]
6. Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.
Rutkoski TJ; Raines RT
Curr Pharm Biotechnol; 2008 Jun; 9(3):185-9. PubMed ID: 18673284
[TBL] [Abstract][Full Text] [Related]
7. Remarkable enhancement of cytotoxicity of onconase and cepharanthine when used in combination on various tumor cell lines.
Ita M; Halicka HD; Tanaka T; Kurose A; Ardelt B; Shogen K; Darzynkiewicz Z
Cancer Biol Ther; 2008 Jul; 7(7):1104-8. PubMed ID: 18443430
[TBL] [Abstract][Full Text] [Related]
8. Glycosylation of onconase increases its conformational stability and toxicity for cancer cells.
Kim BM; Kim H; Raines RT; Lee Y
Biochem Biophys Res Commun; 2004 Mar; 315(4):976-83. PubMed ID: 14985108
[TBL] [Abstract][Full Text] [Related]
9. Constitutive expression and anticancer potency of a novel immunotoxin onconase-DV3.
Sun M; Tang H; Gao Y; Dai X; Yuan Y; Zhang C; Sun D
Oncol Rep; 2016 Apr; 35(4):1987-94. PubMed ID: 26782924
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of activation-induced apoptosis of lymphocytes by the cytotoxic ribonuclease onconase (Ranpirnase).
Halicka DH; Pozarowski P; Ita M; Ardelt WJ; Mikulski SM; Shogen K; Darzynkiewicz Z
Int J Oncol; 2002 Dec; 21(6):1245-50. PubMed ID: 12429974
[TBL] [Abstract][Full Text] [Related]
11. Contribution of active-site residues to the function of onconase, a ribonuclease with antitumoral activity.
Lee JE; Raines RT
Biochemistry; 2003 Oct; 42(39):11443-50. PubMed ID: 14516195
[TBL] [Abstract][Full Text] [Related]
12. Onconase, an anti-tumor ribonuclease suppresses intracellular oxidative stress.
Ardelt B; Juan G; Burfeind P; Salomon T; Wu JM; Hsieh TC; Li X; Sperry R; Pozarowski P; Shogen K; Ardelt W; Darzynkiewicz Z
Int J Oncol; 2007 Sep; 31(3):663-9. PubMed ID: 17671695
[TBL] [Abstract][Full Text] [Related]
13. The crystal structure of the domain-swapped dimer of onconase highlights some catalytic and antitumor activity features of the enzyme.
Gotte G; Campagnari R; Loreto D; Bettin I; Calzetti F; Menegazzi M; Merlino A
Int J Biol Macromol; 2021 Nov; 191():560-571. PubMed ID: 34563576
[TBL] [Abstract][Full Text] [Related]
14. Contribution of chain termini to the conformational stability and biological activity of onconase.
Notomista E; Catanzano F; Graziano G; Di Gaetano S; Barone G; Di Donato A
Biochemistry; 2001 Aug; 40(31):9097-103. PubMed ID: 11478876
[TBL] [Abstract][Full Text] [Related]
15. Enzymatic and structural characterisation of amphinase, a novel cytotoxic ribonuclease from Rana pipiens oocytes.
Singh UP; Ardelt W; Saxena SK; Holloway DE; Vidunas E; Lee HS; Saxena A; Shogen K; Acharya KR
J Mol Biol; 2007 Aug; 371(1):93-111. PubMed ID: 17560606
[TBL] [Abstract][Full Text] [Related]
16. [Onconase: a ribonuclease with antitumor activity].
Zwolińska M; Smolewski P
Postepy Hig Med Dosw (Online); 2010 Feb; 64():58-66. PubMed ID: 20173221
[TBL] [Abstract][Full Text] [Related]
17. A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation.
Castro J; Ribó M; Navarro S; Nogués MV; Vilanova M; Benito A
BMC Cancer; 2011 Jan; 11():9. PubMed ID: 21223552
[TBL] [Abstract][Full Text] [Related]
18. The importance of dynamic effects on the enzyme activity: X-ray structure and molecular dynamics of onconase mutants.
Merlino A; Mazzarella L; Carannante A; Di Fiore A; Di Donato A; Notomista E; Sica F
J Biol Chem; 2005 May; 280(18):17953-60. PubMed ID: 15728177
[TBL] [Abstract][Full Text] [Related]
19. The structural integrity exerted by N-terminal pyroglutamate is crucial for the cytotoxicity of frog ribonuclease from Rana pipiens.
Liao YD; Wang SC; Leu YJ; Wang CF; Chang ST; Hong YT; Pan YR; Chen C
Nucleic Acids Res; 2003 Sep; 31(18):5247-55. PubMed ID: 12954760
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Jurkat acute T-lymphocytic leukemia cells by onconase (Ranpirnase) is accompanied by an altered nucleocytoplasmic distribution and reduced expression of transcription factor NF-kappaB.
Tsai SY; Ardelt B; Hsieh TC; Darzynkiewicz Z; Shogen K; Wu JM
Int J Oncol; 2004 Dec; 25(6):1745-52. PubMed ID: 15547713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]